Drew Kern
Neurology · Aurora, CONPI 1962645697
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 27.9% of the total. Among neurology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $270.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Abbott$19K
- AbbVie$16K
- Boston Scientific$10K
- Insightec,inc$5K
- Neurocrine Biosciences, Inc.$136
- plus $106 from 1 others
Across 205 payments — averaging $5741.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$895K
- Medtronic$170K
- Boston Scientific$112K
What the payments were for
- Consulting fees$26,68839%
- Speaking & faculty fees$16,64425%
- Travel & lodging$14,42821%
- Food & beverage$9,96715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 92 | $18,890 |
| Abbott | 67 | $18,555 |
| AbbVie | 23 | $15,750 |
| Boston Scientific | 28 | $9,532 |
| Insightec,inc | 37 | $4,758 |
| Neurocrine Biosciences, Inc. | 1 | $136 |
| Acadia Pharmaceuticals Inc | 2 | $106 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$16,008
- PERCEPT PC BRAINSENSE$14,947
- VYALEV$4,000
- Exablate$3,877
- Duopa$2,868
- GENERAL DBS$1,686
- VERCISE$1,191
- PROCLAIM$1,181
- GENERAL - THERAPIES$1,014
- Infinity DBS Pulse Generators$285
- ACTIVA$249
- QUADCUT$154
- Percept$145
How this compares
$67,727 in reported general payments places this provider in the 90th percentile of 334 neurology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 82 | $146,685 |
| NeuproRotigotine | 17 | $19,989 |
| Rasagiline Mesylate | 64 | $12,597 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 156 | $5,576 |
| Entacapone | 19 | $4,145 |
| Rivastigmine | 11 | $2,089 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 36 | $1,570 |
| AmantadineAmantadine Hcl | 26 | $1,109 |
| Gabapentin | 36 | $1,021 |
| Clonazepam | 61 | $937 |
| Propranolol Hcl | 19 | $642 |
| Glycopyrrolate | 12 | $408 |
| Primidone | 14 | $381 |
| Methylphenidate Hcl | 18 | $366 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 18 | $136 |
Paid to pharmacies, not to this prescriber.
Other neurology in Aurora
- Jeffrey BennettAurora$605K
- Enrique AlvarezAurora$407K
- Anna ShahAurora$157K
- Timothy VollmerAurora$136K
- Simon OhAurora$112K
- Amanda PiquetAurora$106K
- Brent MorelAurora$79K
- Ondrea TimmermannAurora$33K
- Thomas RagoleAurora$31K
- Maria NagelAurora$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.